USC / Norris Comprehensive Cancer Center — Los Angeles, California

Public research footprint of USC / Norris Comprehensive Cancer Center, compiled from the ClinicalTrials.gov public registry.

1,213

Registered studies

383

Active

174

Recruiting now

536

Completed

259

Stopped or withdrawn

Most-studied conditions

Myelodysplastic Syndrome With Excess Blasts · Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Metastatic Non-Cutaneous Melanoma · Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05600894 — Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at USC / Norris Comprehensive Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.